Monkeypox is a zoonosis first described in a human patient in 1970, when the virus was isolated from a 9-month-old patient with smallpox suspicion in the Democratic Republic of Congo.

It is a neglected endemic zoonotic disease in the tropical rainforest regions of Central and West Africa. In 2003, the first outbreak of Monkeypox virus infection reported outside the endemic areas was reported in United States, and later, few travel-associated cases were reported outside Africa. However, in 2022 we are experiencing an escalating outbreak with more than 23 thousand confirmed cases around the world.

Monkeypox clinical manifestations include fever, skin lesions (macules, papules, vesicles, and pustules) and lymphadenopathy. This symptomatology can be mistaken for other severe viral infections.

Vitassay Healthcare offers a new Vitassay qPCR kit for the detection of Monkeypox virus.

Importantly, our lyophilised kits can be combined to create the best panel to facilitate a differential diagnosis with Varicella Zoster Virus, HSV-1, HSV-2 and T. pallidum (syphilis) infection.

Count on Vitassay for the best diagnosis!